Product Details

Teva-Combo Sterinebs

Ipratropium Bromide + Salbutamol
500 mcg + 2.5 mg/2.5 mL
Inhalation Solution
2.5-mL Ampoule Pack

DIN/PIN/NPN

02272695

Manufacturer

Teva Canada Limited

Formulary Listing Date

2006-01-24  

Unit Price

0.8066

Amount MOH Pays

0.8066

Coverage Status

Limited Use Product

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

R03AL02

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02272695 Teva-Combo Sterinebs 0.8066 0.8066
02483394 Ipratropium Bromide and Salbutamol Sulph 0.8066 0.8066
02231675 Combivent UDV NA NA
 

LU Clinical Criteria

LU Code Auth. Period Clinical Criteria
Note: For the vast majority of patients, a metered dose inhaler is the preferred therapy. Nebulizer therapy will be reimbursed for patients who are unable to use a metered dose inhaler, including an inhaler with a spacer attachment, or a turbuhaler.
256 Indefinite

Patients who have a tracheostomy;

257 Indefinite

Patients with cystic fibrosis in whom nebulizer therapy is indicated;

258 Indefinite

Patients with severe mental or physical disabilities;

259 Indefinite

Patients who have previously used nebulizer therapy within the last 12-month period.

 

EAP Criteria

NO

Product Monograph

View Monograph